Previous 10 | Next 10 |
DocuSign Inc. (DOCU) is expected to report $0.11 for Q2 2024 Firm Capital Property Trust Unit (FRMUF) is expected to report for Q1 2024 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Concrete Pumping Holdings Inc. (BBCP) is expected to report $0.16 for Q3 2023 ...
Sio Gene Therapies Inc. (SIOX) is expected to report for quarter end 2023-06-30
2023-04-28 03:30:00 ET Summary Alluvial Fund follows the same successful investment strategies used by Alluvial in managing separate accounts, focusing on value opportunities in small companies and thinly-traded issues, both domestically and internationally. Alluvial Fund began th...
2023-04-20 08:17:26 ET Summary This is a failed biopharma liquidation play with a favorable risk-reward. Sio Gene Therapies is undergoing liquidation, with its shareholders likely to receive $0.38-$0.42/share vs. the current price of $0.40/share. An additional upside of up to ...
Sio Gene Therapies press release ( NASDAQ: SIOX ): Q3 GAAP EPS of -$0.05. As of December 31, 2022, we had $46.13 million of cash and cash equivalents. For further details see: Sio Gene Therapies GAAP EPS of -$0.05
– Three-Month and Nine-Month Losses decline by 84.2% and 73.5%, respectively – Operating Cash Outflows for the Nine Months Ended December 31, 2022 decreased by $23.8 million or 56% versus the prior year period – $46.1 million of c...
NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (Nasdaq:SIOX) today announced that its Board of Directors has determined, after extensive and careful consideration of potential strategic alternatives, that it is in the best interests of the Company and its shareholders to diss...
Sio Gene Therapies press release ( NASDAQ: SIOX ): Q2 GAAP EPS of -$0.04 beats by $0.15 . As of September 30, 2022, Company had $49.86 million of cash and cash equivalents. For further details see: Sio Gene Therapies GAAP EPS of -$0.04 beats by $0.15
- Three-Month and Six-Month Losses decline by 85.5% and 65.3%, respectively - Operating Cash Outflows for the Six Months Ended September 30, 2022 decreased by $8.1 million or 37% versus the prior year period - Strong cash position with $49.86 million of cash and cash equiv...
Cheap Penny Stocks to Buy For Under $1 If you’re watching the action in the stock market today, you’re seeing plenty of chop. The U.S. dollar’s strength has pushed broader markets lower, but a mix of positive and negative economic against this week’s PPI data...
News, Short Squeeze, Breakout and More Instantly...
Sio Gene Therapies Inc. Company Name:
SIOX Stock Symbol:
NASDAQ Market:
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...